U.S. Auto Stock News

Sherwin-Williams reported third-quarter earnings and revenue that beat expectations, supported by higher prices and strong performance across its core business segments. The company's recent acquisition of Suvinil was also highlighted in its updated full-year guidance. See our latest analysis for Sherwin-Williams. Sherwin-Williams’ solid quarterly results and timely acquisition of Suvinil come after a year marked by resilient performance, with the share price up 2.5% year-to-date. The company...

Newell Brands recently announced a global productivity plan involving a 10% reduction in its workforce and closure of approximately 20 stores worldwide, aiming for US$110 million to US$130 million in annualized cost savings by 2026 with anticipated restructuring charges of US$75 million to US$90 million. This restructuring is part of the company's turnaround efforts focused on automation, digitization, and streamlining operations to drive future efficiency improvements. We'll now explore how...

FTAI Aviation (FTAI) is attracting investor attention after recent analyst commentary spotlighted several events on the horizon, including an upcoming investor day, FAA approval prospects, and a possible new capital initiative. The company’s strong financial track record adds more interest as investors weigh the outlook and next steps. See our latest analysis for FTAI Aviation. FTAI Aviation’s recent momentum stands out, with the stock boasting a 17.1% year-to-date share price return as...

ORIC Pharmaceuticals (ORIC) drew fresh investor attention after announcing it will present Phase 1b clinical data for enozertinib in previously treated HER2 exon 20 mutant NSCLC at the ESMO Asia Congress this week. See our latest analysis for ORIC Pharmaceuticals. Excitement around ORIC Pharmaceuticals’ upcoming clinical data release has arrived following a period of strong price momentum. Shares have climbed 35% so far in 2024, with a notable 7% gain over the past three months, helping to...

Powell Industries (POWL) caught investor interest after releasing its fourth quarter and full-year earnings, highlighting sequential gains in both sales and profits compared to last year. The latest results signal positive momentum for the company. See our latest analysis for Powell Industries. Powell Industries' upbeat results have added fuel to an already impressive streak, with its share price notching a 21.16% gain over the past three months. Looking longer term, the company’s total...

Ardagh Metal Packaging (NYSE:AMBP) just completed a dual-currency offering of senior secured green notes. The company raised funds for refinancing existing debt and redeeming preferred shares. This move could reshape the company’s capital structure and sustainability profile. See our latest analysis for Ardagh Metal Packaging. The recent refinancing moves arrive as Ardagh Metal Packaging’s share price has built steady momentum. Its year-to-date share price return stands at 27.6%, while the...

KKR (KKR) just backed a major UK logistics and industrial portfolio by providing a £350 million refinancing through its managed funds and accounts. This move gives Cain room to advance leasing efforts and highlights KKR’s long-term confidence in real estate fundamentals. See our latest analysis for KKR. Despite KKR’s strategic moves in real estate and the broader market, the stock price has come under pressure this year, with an 18.1% share price decline year to date. Over the past year,...

In November 2025, Allstate announced the launch of Scam Protection as a workplace benefit to address growing digital threats like scams, ransomware, and cryptocurrency theft, offering reimbursement of up to US$50,000 per fraud event and extending coverage to employees' families, including seniors and teens. This move comes as cybercrime surges during the holiday season, with Allstate reporting customer savings of US$33.2 million from potential fraud losses last year, highlighting employer...

Uber Technologies (NYSE:UBER) is pushing into new territory this week, rolling out fully driverless Robotaxi operations in Abu Dhabi with WeRide. This milestone marks Uber’s first autonomous service deployment in the Middle East and outside the US. See our latest analysis for Uber Technologies. Uber’s push into autonomous mobility comes at a time of notable share price momentum, with a robust year-to-date share price return of 37% and a three-year total shareholder return of 213%. While...

Xeris Biopharma Holdings (XERS) announced a Notice of Allowance for its XP-8121 patent application. This development could enhance its intellectual property position for a novel hypothyroidism therapy and support future commercialization plans. See our latest analysis for Xeris Biopharma Holdings. Even with a one-day share price dip of 3.06% and a tougher month, Xeris Biopharma’s long-term momentum is notable. Its year-to-date share price return is 101.16%, and the total shareholder return...

Vertiv and Caterpillar announced in November 2025 a collaboration to integrate advanced energy optimization and cooling solutions for data centers, combining Vertiv’s modular portfolio with Caterpillar’s power generation and CCHP expertise. This alliance enables more efficient, on-site energy and cooling architectures designed to accelerate deployment and reduce grid dependence for customers amid rising AI and cloud infrastructure needs. We’ll explore how Vertiv’s joint focus on energy...

PTC Therapeutics (PTCT) has been under the spotlight recently, with investors chatting about its steady gains over the past month. The company’s stock has climbed 16% during this period, which has caught the attention of both seasoned and new market watchers. See our latest analysis for PTC Therapeutics. Despite a sharp one-day dip, PTC Therapeutics has sustained a remarkable run so far this year, with a 16% share price return over the past month and an impressive 73% rise year to date. While...

In late November 2025, Sarepta Therapeutics announced two major developments: FDA approval to begin dosing non-ambulant Duchenne muscular dystrophy patients with ELEVIDYS in a new ENDEAVOR study cohort, and progress in the Phase 1/2 multiple ascending dose clinical trial for SRP-1003, its investigational siRNA therapy for type 1 myotonic dystrophy. These advancements underscore Sarepta's commitment to expanding its pipeline and addressing rare neuromuscular diseases with innovative genetic...

American Electric Power Company (AEP) has just announced a follow-on equity offering worth $3.5 billion, structured as an at-the-market transaction. This move has drawn attention as investors consider what it might mean for the company’s future plans and capital needs. See our latest analysis for American Electric Power Company. With American Electric Power Company's latest $3.5 billion equity raise making headlines, the market has already been showing strong momentum. This year’s share price...

On November 17, 2025, The RealReal, Inc. announced that Gilbert L. (Chip) Baird III resigned from its Board of Directors following the sale of GreyLion Partners LP's shareholding in the company. This departure marks a significant transition in governance, as a key pre-IPO investor representative exits the board while continuing to consult for RealReal until mid-2026. We'll examine how the exit of a major investor's board representative could influence RealReal's long-term business priorities...

Acadian Asset Management (NYSE:AAMI) has seen shifts in its stock performance over the past month, catching the attention of market watchers. Investors are evaluating whether recent trends offer opportunities for those tracking asset management firms. See our latest analysis for Acadian Asset Management. While Acadian Asset Management’s share price has dipped 8.8% over the past month, the broader picture reveals robust momentum. Its year-to-date share price return stands at an impressive 70%,...

Belite Bio (BLTE) reported that Tinlarebant, its experimental treatment for Stargardt disease, achieved the primary endpoint in a pivotal global Phase 3 trial. The results highlight Tinlarebant’s potential to address a significant unmet medical need. See our latest analysis for Belite Bio. Belite Bio’s share price has risen sharply in response to the Tinlarebant trial news, climbing 12% on the day and delivering a 45% share price return over the last month. After reaching record highs,...

Wolfe Research recently initiated coverage on Soleno Therapeutics, providing a positive outlook for ViCAT XR after concerns were raised over its safety and commercial prospects. This coverage comes in the wake of both a short seller report and ongoing legal investigations, reflecting heightened scrutiny and contrasting expert perspectives for investors. We’ll explore how Wolfe Research’s assessment of ViCAT XR’s insurance access and patient growth prospects shapes the company’s investment...

Plexus (PLXS) just surpassed expectations with its fourth-quarter earnings, reporting an earnings per share of $2.14. This clear beat has quickly put the company on investors’ radar and has prompted discussion about its future growth prospects. See our latest analysis for Plexus. Plexus’s standout quarterly results have come amid a year of mixed share price momentum. Despite a recent 3.04% gain over the past week and a steady 5.41% share price return for the quarter, its year-to-date share...

Curious whether PepsiCo is actually a bargain, or if the stock’s price tag is starting to outpace its value? You’re not alone, and digging into its valuation might reveal some insightful surprises. Despite a year-to-date dip of 0.5% and a 4.8% slide over the last twelve months, PepsiCo shares have rebounded with a 2.8% gain this past week, hinting at renewed optimism from investors. One reason behind these movements is heightened analyst attention, as PepsiCo's diversified snack and beverage...

Alarm.com Holdings (ALRM) has seen some movement in its stock price recently, prompting investors to take a closer look at the company’s performance and outlook. The stock is coming off a month in which it posted a 4% gain. See our latest analysis for Alarm.com Holdings. Alarm.com Holdings’ recent 1-month share price return of 4.45% has offered some relief after a challenging year, with momentum starting to stabilize despite a 1-year total shareholder return of -20.49%. While short-term...

Raymond James Financial recently reported strong fiscal year results as of September 30, 2025, with substantial growth in revenues and earnings supported by its wealth management business managing over US$1.7 trillion in client assets. The company’s continued focus on regulatory compliance and cybersecurity remains central to its operational strategy as it seeks to enhance shareholder value and maintain financial stability. We’ll explore how Raymond James Financial’s improved financial...

Nebius Group (NBIS) has caught some attention lately as investors react to shifts in its business performance and broader market sentiment. The company’s recent swings in returns raise some intriguing questions about value and momentum going forward. See our latest analysis for Nebius Group. Nebius Group’s share price has been riding waves of market excitement, with a standout 228% return year-to-date and a hefty 289% total shareholder return over the past year. After an explosive multi-month...

Wondering if Goldman Sachs Group is a steal or overpriced in today’s market? You’re not alone. This stock has caught the eye of many value-seeking investors lately. Goldman’s stock price has surged, with an impressive 41.0% gain year-to-date and a 36.8% return over the last year. This trend hints at renewed optimism around its future prospects. Several headlines have helped drive momentum, including Goldman’s bold expansion into wealth management and recent leadership shakeups that signal...